Inhibition of nitric oxide formation by aminoguanidine: An attempt to prevent insulin-dependent diabetes mellitus
- 1 November 1997
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 29 (5) , 697-700
- https://doi.org/10.1016/s0306-3623(97)00012-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Aminoguanidine Ameliorates and l -Arginine Worsens Brain Damage From Intraluminal Middle Cerebral Artery OcclusionStroke, 1996
- Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.Journal of Clinical Investigation, 1994
- Requirement for Transcription Factor IRF-1 in NO Synthase Induction in MacrophagesScience, 1994
- Effects of NG-Methyl-L-arginine, NG-Nitro-L-arginine, and Aminoguanidine on Constitutive and Inducible Nitric Oxide Synthase in Rat AortaBiochemical and Biophysical Research Communications, 1994
- Nitric Oxide and Arginine-Evoked Insulin SecretionScience, 1992
- Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitorLife Sciences, 1991
- Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analoguesLife Sciences, 1991
- Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in miceBiochemical and Biophysical Research Communications, 1991
- Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanismFEBS Letters, 1990
- Type I Diabetes MellitusNew England Journal of Medicine, 1986